The DOI matches its Crossref record; 218 of the 218 references it cites were found in a registry or an index.
Nanoparticles: Alternatives Against Drug-Resistant Pathogenic Microbes
Open accessAbstract
Antimicrobial substances may be synthetic, semisynthetic, or of natural origin (i.e., from plants and animals). Antimicrobials are considered “miracle drugs” and can determine if an infected patient/animal recovers or dies. However, the misuse of antimicrobials has led to the development of multi-drug-resistant bacteria, which is one of the greatest challenges for healthcare practitioners and is a significant global threat. The major concern with the development of antimicrobial resistance is the spread of resistant organisms. The replacement of conventional antimicrobials by new technology to counteract antimicrobial resistance is ongoing. Nanotechnology-driven innovations provide hope for patients and practitioners in overcoming the problem of drug resistance. Nanomaterials have tremendous potential in both the medical and veterinary fields. Several nanostructures comprising metallic particles have been developed to counteract microbial pathogens. The effectiveness of nanoparticles (NPs) depends on the interaction between the microorganism and the NPs. The development of effective nanomaterials requires in-depth knowledge of the physicochemical properties of NPs and the biological aspects of microorganisms. However, the risks associated with using NPs in healthcare need to be addressed. The present review highlights the antimicrobial effects of various nanomaterials and their potential advantages, drawbacks, or side effects. In addition, this comprehensive information may be useful in the discovery of broad-spectrum antimicrobial drugs for use against multi-drug-resistant microbial pathogens in the near future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Retracted: Characterization of enhanced antibacterial effects of novel silver nanoparticles
Shrivastava, S., Bera, T., Roy, A., Singh, G., Ramachandrarao, P., & Dash, D. (2007) · Nanotechnology · doi:10.1088/0957-4484/18/22/225103 · Cited by 1,523
RetractedProspects and applications of nanobiotechnology: a medical perspective
Fakruddin, M., Hossain, Z., & Afroz, H. (2012) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-10-31 · Cited by 284
RetractedDaniel, M.-C., & Astruc, D. (2004) · Chemical Reviews · doi:10.1021/cr030698+ · Cited by 12,446
The bactericidal effect of silver nanoparticles
Morones, J. R., Elechiguerra, J. L., Camacho, A., Holt, K., Kouri, J. B., Ramírez, J. T., & Yacaman, M. J. (2005) · Nanotechnology · doi:10.1088/0957-4484/16/10/059 · Cited by 6,668
Preparation and Growth Mechanism of Gold Nanorods (NRs) Using Seed-Mediated Growth Method
Nikoobakht, B., & El-Sayed, M. A. (2003) · Chemistry of Materials · doi:10.1021/cm020732l · Cited by 5,069
Antibiotic resistance-the need for global solutions
Laxminarayan, R., Duse, A., Wattal, C., Zaidi, A. K. M., Wertheim, H. F. L., Sumpradit, N., Vlieghe, E., Hara, G. L., Gould, I. M., Goossens, H., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70318-9 · Cited by 4,439
Nanomaterials and nanoparticles: Sources and toxicity
Buzea, C., Pacheco, I. I., & Robbie, K. (2007) · Biointerphases · doi:10.1116/1.2815690 · Cited by 3,789
Biodegradable polymeric nanoparticles based drug delivery systems
Kumari, A., Yadav, S. K., & Yadav, S. C. (2010) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2009.09.001 · Cited by 3,724
Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity
Boisselier, E., & Astruc, D. (2009) · Chemical Society Reviews · doi:10.1039/b806051g · Cited by 2,842
On the mechanisms of biocompatibility
Williams, D. F. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.04.023 · Cited by 2,772
Cited by
Nano based drug delivery systems: recent developments and future prospects
Patra, J. K., Das, G., Fraceto, L. F., Campos, E. V. R., Rodriguez-Torres, M. D. P., Acosta-Torres, L. S., Diaz-Torres, L. A., Grillo, R., Swamy, M. K., Sharma, S., et al. (2018) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0392-8 · Cited by 6,684
Self-citationMetal-Based Nanoparticles as Antimicrobial Agents: An Overview
Sánchez-López, E., Gomes, D., Esteruelas, G., Bonilla, L., Lopez-Machado, A. L., Galindo, R., Cano, A., Espina, M., Ettcheto, M., Camins, A., et al. (2020) · Nanomaterials · doi:10.3390/nano10020292 · Cited by 1,474
Swamy, M. K., Akhtar, M. S., & Sinniah, U. R. (2016) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2016/3012462 · Cited by 949
Self-citationRecent advances on antimicrobial wound dressing: A review
Simões, D., Miguel, S. P., Ribeiro, M. P., Coutinho, P., Mendonça, A. G., & Correia, I. J. (2018) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2018.02.022 · Cited by 935
Nano-Strategies to Fight Multidrug Resistant Bacteria—“A Battle of the Titans”
Baptista, P. V., McCusker, M. P., Carvalho, A., Ferreira, D. A., Mohan, N. M., Martins, M., & Fernandes, A. R. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01441 · Cited by 881
Tariq, S., Wani, S., Rasool, W., Shafi, K., Bhat, M. A., Prabhakar, A., Shalla, A. H., & Rather, M. A. (2019) · Microbial Pathogenesis · doi:10.1016/j.micpath.2019.103580 · Cited by 693
Nanoparticles in the Treatment of Infections Caused by Multidrug-Resistant Organisms
Lee, N.-Y., Ko, W.-C., & Hsueh, P.-R. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01153 · Cited by 532
Face Masks in the New COVID-19 Normal: Materials, Testing, and Perspectives
Chua, M. H., Cheng, W., Goh, S. S., Kong, J., Li, B., Lim, J. Y. C., Mao, L., Wang, S., Xue, K., Yang, L., et al. (2020) · Research · doi:10.34133/2020/7286735 · Cited by 495
Huang, Y., Guo, X., Wu, Y., Chen, X., Feng, L., Xie, N., & Shen, G. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01745-z · Cited by 490
Terpene Derivatives as a Potential Agent against Antimicrobial Resistance (AMR) Pathogens
Mahizan, N. A., Yang, S.-K., Moo, C.-L., Song, A. A.-L., Chong, C.-M., Chong, C.-W., Abushelaibi, A., Lim, S.-H. E., & Lai, K.-S. (2019) · Molecules · doi:10.3390/molecules24142631 · Cited by 473
Chitosan-Based Nanoparticles as Effective Drug Delivery Systems—A review
Jafernik, K., Ładniak, A., Blicharska, E., Czarnek, K., Ekiert, H., Wiącek, A. E., & Szopa, A. (2023) · Molecules · doi:10.3390/molecules28041963 · Cited by 460
Mechanistic study on antibacterial action of zinc oxide nanoparticles synthesized using green route
Agarwal, H., Menon, S., Venkat Kumar, S., & Rajeshkumar, S. (2018) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2018.03.008 · Cited by 447
Nanocurcumin: A Promising Candidate for Therapeutic Applications
Karthikeyan, A., Senthil, N., & Min, T. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00487 · Cited by 414
Development of botanicals to combat antibiotic resistance
Gupta, P. D., & Birdi, T. J. (2017) · Journal of Ayurveda and Integrative Medicine · doi:10.1016/j.jaim.2017.05.004 · Cited by 371
Zhou, X.-Q., Hayat, Z., Zhang, D.-D., Li, M.-Y., Hu, S., Wu, Q., Cao, Y.-F., & Yuan, Y. (2023) · Processes · doi:10.3390/pr11041193 · Cited by 368
Essential Oils and Their Application in Food Safety
Maurya, A., Prasad, J., Das, S., & Dwivedy, A. K. (2021) · Frontiers in Sustainable Food Systems · doi:10.3389/fsufs.2021.653420 · Cited by 349
Nanotechnology-based antiviral therapeutics
Chakravarty, M., & Vora, A. (2021) · Drug Delivery and Translational Research · doi:10.1007/s13346-020-00818-0 · Cited by 334
Vazquez-Muñoz, R., Meza-Villezcas, A., Fournier, P. G. J., Soria-Castro, E., Juarez-Moreno, K., Gallego-Hernández, A. L., Bogdanchikova, N., Vazquez-Duhalt, R., & Huerta-Saquero, A. (2019) · PLOS ONE · doi:10.1371/journal.pone.0224904 · Cited by 307
Essential oils and its antibacterial, antifungal and anti-oxidant activity applications: A review
Hou, T., Sana, S. S., Li, H., Xing, Y., Nanda, A., Netala, V. R., & Zhang, Z. (2022) · Food Bioscience · doi:10.1016/j.fbio.2022.101716 · Cited by 284
Vazquez-Munoz, R., Lopez, F. D., & Lopez-Ribot, J. L. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01673 · Cited by 59
Ameur, E., Sarra, M., Yosra, D., Mariem, K., Nabil, A., Lynen, F., & Larbi, K. M. (2021) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-021-03379-y · Cited by 36
Kotha, R., Fernandes, G., Nikam, A. N., Kulkarni, S., Pandey, A., Pandey, S., & Mutalik, S. (2020) · Materials Science and Technology · doi:10.1080/02670836.2020.1832323 · Cited by 17
Vishwakarma, K. K., Hafeez, A., Usmani, S. A., Noor, L., & Khan, I. R. (2025) · Current Pharmaceutical Biotechnology · doi:10.2174/0113892010318524240907135527 · Cited by 4
Metadata
- Authors
- Rudramurthy, G., Swamy, M., Sinniah, U., & Ghasemzadeh, A.
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2016-06-27
- Volume
- 21
- Issue
- 7
- Pages
- 836
- ISSN
- 1420-3049 (ISSN-L)
- OpenAlex
- W2473736632
- Cited by
- 556
- References
- 218
- FWCI
- 16.01
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.